This narrative review presents an overview of current knowledge on fertility and reproductive
hormone changes in aging men, the factors driving and modulating these changes, their …

Alzheimer's disease (AD) is a neurodegenerative disease responsible for almost half of all
dementia cases in the world and progressively increasing. The etiopathology includes …

Background In advanced prostate cancer (APC), successful drug development as well as
advances in imaging and molecular characterisation have resulted in multiple areas where …

Importance The use of second-generation antiandrogens (AAs) in the treatment of prostate
cancer is increasing. Retrospective evidence suggests an association between second …

Importance The association between androgen deprivation therapy (ADT) exposure and
dementia is uncertain. Objective To analyze the association between ADT exposure and …

Study Objective To examine the risks and compare the occurrences of major long‐term side
effects (sexual dysfunction, bone fractures, diabetes, cardiovascular morbidity, acute …

Purpose: Androgen deprivation therapy is a standard therapy for some patients with
localized and almost all patients with metastatic prostate cancer. Although several clinical …

Background. Mortality from noncancer causes in patients with prostate cancer (PCa) is
unclear. This study assesses the causes and risks of noncancer death with each follow‐up …

Background: Androgen deprivation therapy (ADT) to treat prostate cancer may be
associated with an increased risk of dementia, but existing studies have shown conflicting …

Simple Summary As survival rates for cancer increase and most patients exceed the age of
65 years, more emphasis has gone to possible cognitive sequelae, which could be …